Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BIII 890 CL

Known as: 1,2,3,4,5,6-hexahydro-6,11,11-trimethyl-3-(2-(phenylmethoxy)propyl)-2,6-methano-3-benzazocin-10-ol, BIII-890-CL 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
  • J. Meythaler
  • Current opinion in investigational drugs
  • 2002
  • Corpus ID: 2158593
BIII-890-CL is a non-orally active sodium channel blocker under development by Boehringer Ingelheim Corp for the potential… Expand
2000
2000
We have synthesized a new benzomorphan derivative, 2R-[2alpha,3(S*), 6alpha]-1,2,3,4,5,6-hexahydro-6,11, 11-trimethyl-3-[2… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3